
News|Articles|January 26, 2026
AAP updates guidance on therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy
Author(s)Morgan Ebert, Executive Editor
Fact checked by: Celeste Krewson, Assistant Editor
AAP updated guidance supports therapeutic hypothermia for term infants with moderate to severe HIE, emphasizing early initiation and specialized care.
Advertisement
Advertisement
The American Academy of Pediatrics (AAP) has released an updated clinical report providing revised guidance on the use of therapeutic hypothermia for newborns with neonatal hypoxic-ischemic encephalopathy (HIE). The report, Therapeutic Hypothermia for Neonatal Hypoxic-Ischemic Encephalopathy, was published in the February 2026 issue of Pediatrics and updates an AAP policy statement first issued in 2014.1,2
Related to this article

A meta-analysis of 7 real-world studies found maternal RSVpreF 78% effective against RSV LRTI hospitalization in infants up to 6 months.

Pumpkin carving accounts for 55% of Halloween ED injuries; AAOS outlines prevention tips for carving, costumes, and trick-or-treating.

The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.

The US lost measles elimination status after 26 years; CDC and partners plan to regain it via MMR vaccination and $100M in health department funding.

At ACAAI 2026, 93.6% of pediatric biologic prescriptions needed prior authorization, 39.3% were denied, and approval took a mean of 33 days.

US preterm birth rate held at 10.4%, earning a fifth straight D+ from March of Dimes; maternal deaths fell, but racial disparities persist.

In SURMOUNT-ADOLESCENTS, tirzepatide cut BMI 18.5% at 72 weeks vs a 0.5% rise with placebo in adolescents with obesity.
Advertisement
Advertisement

